Science Vorasidenib Gains Rapid Adoption in IDH-Mutated Glioma Treatment Vorasidenib (marketed as Voranigo) is rapidly becoming a significant option in the treatment of IDH-mutated glioma, according to findings from a real-world study presented... Editorial2 hours ago